Showing results (1-10 of 720) with videos related to
Sort By:
Pageof 72
Seminars in Hematology|January 15, 2011
Role of microRNAs from monoclonal gammopathy of undetermined significance to multiple myelomaKatherine R Calvo, Ola Landgren, Aldo M Roccaro, et al.Seminars in Hematology|May 16, 2018
MRD Testing in Multiple Myeloma: From a Surrogate Marker of Clinical Outcomes to an Every-Day Clinical ToolOla LandgrenHematology. American Society of Hematology. Education Program|December 10, 2013
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma: biological insights and early treatment strategiesOla LandgrenLeukemia|May 5, 2026
Smoldering multiple myeloma in transition: redefining early myeloma in the modern eraOla LandgrenHematology. American Society of Hematology. Education Program|December 10, 2017
Shall we treat smoldering multiple myeloma in the near future?Ola LandgrenHematology. American Society of Hematology. Education Program|January 18, 2011
Monoclonal gammopathy of undetermined significance and smoldering myeloma: new insights into pathophysiology and epidemiologyOla LandgrenSeminars in Oncology|January 8, 2017
Combination therapy for fit (younger and older) newly diagnosed multiple myeloma patients: Data support carfilzomib, lenalidomide, and dexamethasone independent of cytogenetic risk statusOla LandgrenHematology. American Society of Hematology. Education Program|December 10, 2021
Advances in MGUS diagnosis, risk stratification, and management: introducing myeloma-defining genomic eventsOla LandgrenPageof 72